Alyssa La Belle Flynn

3PUBLICATIONS
18CO-AUTHORS
Molecular targetsTumour immunologyCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Jan 08, 2026
TPP-45142-an Anti-HER2 T-cell Engager-Designed for Selective HER2-Low Cancer Immunotherapy.

Evelyn De Tavernier, Peter S Kim, Eduardo M Bruch

|Oct 18, 2023
RGS1 Modulates Autophagic and Metabolic Programs and Is a Critical Mediator of Human Regulatory T Cell Function.

Alyssa L Flynn, Joseph Gans, Javier Escobedo

|Aug 16, 2019
Autophagy inhibition elicits emergence from metastatic dormancy by inducing and stabilizing Pfkfb3 expression.

Alyssa La Belle Flynn, Benjamin C Calhoun, Arishya Sharma

Pageof 1

Frequent Collaborators

2 joint publications

Lily I Pao

1 joint publications

Srinivas Shankara

1 joint publications

Evelyn De Tavernier

1 joint publications

Peter S Kim

1 joint publications

Eduardo M Bruch

1 joint publications

Virna F Cortez-Retamozo

1 joint publications

Lien Timmerman

1 joint publications

Wouter Van Overbeke

1 joint publications

Fabrice Tirode

1 joint publications

Valeria Cintra Barbosa-Lorenzi

Frequent Collaborators

2 joint publications

Lily I Pao

1 joint publications

Srinivas Shankara

1 joint publications

Evelyn De Tavernier

1 joint publications

Peter S Kim

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on : Jun 13, 2014

17.0K
<em>In Vitro</em> Differentiation of Human CD4<sup>+</sup>FOXP3<sup>+</sup> Induced Regulatory T Cells (iTregs) from Na&#239;ve CD4<sup>+</sup> T Cells Using a TGF-&#946;-containing Protocol
08:20

<em>In Vitro</em> Differentiation of Human CD4<sup>+</sup>FOXP3<sup>+</sup> Induced Regulatory T Cells (iTregs) from Na&#239;ve CD4<sup>+</sup> T Cells Using a TGF-&#946;-containing Protocol

Published on : Dec 30, 2016

20.5K
An <em>In Vitro</em> System to Study Tumor Dormancy and the Switch to Metastatic Growth
09:14

An <em>In Vitro</em> System to Study Tumor Dormancy and the Switch to Metastatic Growth

Published on : Aug 11, 2011

16.3K
See more related videos

Top Related Videos

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on : Jun 13, 2014

17.0K
<em>In Vitro</em> Differentiation of Human CD4<sup>+</sup>FOXP3<sup>+</sup> Induced Regulatory T Cells (iTregs) from Na&#239;ve CD4<sup>+</sup> T Cells Using a TGF-&#946;-containing Protocol
08:20

<em>In Vitro</em> Differentiation of Human CD4<sup>+</sup>FOXP3<sup>+</sup> Induced Regulatory T Cells (iTregs) from Na&#239;ve CD4<sup>+</sup> T Cells Using a TGF-&#946;-containing Protocol

Published on : Dec 30, 2016

20.5K
An <em>In Vitro</em> System to Study Tumor Dormancy and the Switch to Metastatic Growth
09:14

An <em>In Vitro</em> System to Study Tumor Dormancy and the Switch to Metastatic Growth

Published on : Aug 11, 2011

16.3K
See more related videos